| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.976 | 0 | 0 | - | - | - | - | - | - | - |
| Total Income - EUR | 5.976 | 0 | 0 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 12.258 | 4.879 | 2.095 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -6.282 | -4.879 | -2.095 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -6.282 | -4.907 | -2.095 | - | - | - | - | - | - | - |
| Employees | 1 | 0 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Lynndent Laboratory Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.257 | 5.052 | 2.871 | - | - | - | - | - | - | - |
| Current Assets | 72.258 | 67.060 | 65.925 | - | - | - | - | - | - | - |
| Inventories | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Receivables | 70.600 | 64.673 | 63.578 | - | - | - | - | - | - | - |
| Cash | 1.613 | 2.343 | 2.303 | - | - | - | - | - | - | - |
| Shareholders Funds | 49.216 | 43.807 | 40.970 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Debts | 30.335 | 28.341 | 27.861 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Lynndent Laboratory Srl